Breaking News Instant updates and real-time market news.

GIS

General Mills

$53.04

-0.52 (-0.97%)

13:08
07/09/19
07/09
13:08
07/09/19
13:08

General Mills notes accelerating organic net sales growth among FY20 priorities

General Mills announced in a press release that it updated investors and analysts on the company's fiscal 2020 priorities at its annual Investor Day, held today. In FY20, General Mills said it will focus on delivering balanced top and bottom-line growth with innovation and brand building at the center of its agenda. Priorities include: Accelerating organic net sales growth through improved performance in its North America Retail segment and continued strong growth in its Pet segment; Maintaining strong margins, fueled by benefits from Holistic Margin Management and Strategic Revenue Management initiatives; and reducing leverage through a disciplined focus on cash and debt repayment to achieve its FY20 leverage target of 3.5 times net-debt-to-adjusted EBITDA.

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

GIS General Mills
$53.04

-0.52 (-0.97%)

05/28/19
05/28/19
DOWNGRADE
Target $41

Sell
General Mills cut to Sell at Goldman Sachs on deceleration concerns
As previously reported, Goldman Sachs analyst Jason English downgraded General Mills to Sell from Neutral with a price target of $41. The analyst notes that after a period of outperformance from sequential improvement in the company's core business and the impact of its acquisition of Blue Buffalo, General Mills is entering its next "chapter" of "mounting deceleration." English adds that while the benefits of the management's improvement initiatives are still "peaking" and his perceived risk to estimates for the company is two or more quarters away, the stock is also trading near its multi-year high earnings multiple with the upside risk from current levels likely limited.
05/29/19
05/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Mills (GIS) downgraded to Sell from Neutral at Goldman Sachs with analyst Jason English saying that after a period of outperformance from sequential improvement in the company's core business and the impact of its acquisition of Blue Buffalo, General Mills is entering its next "chapter" of "mounting deceleration." 2. NIO Inc. (NIO) downgraded to Underperform from Neutral at BofA/Merrill with analyst Ming Hsun Lee saying he expects weak orders for the ES8 and ES6 due to EV purchase subsidy cuts, less cash flow from reduced car sales, increased competition from Tesla's (TSLA) Model 3 in 2020, and views valuation as "rich." 3. American Campus (ACC) downgraded to Market Perform from Outperform at JMP Securities with analyst Aaron Hecht saying his firm's checks at UC Berkeley indicate that the 6,000 bed RFP will likely end up being fee-based development, which takes one of his previously expected catalysts off the table. 4. Atlassian (TEAM) downgraded to Neutral from Buy at BTIG with analyst Edward Parker saying after a "great run" of over 100% in the last 12 months, the risk-reward on the stock has turned more "balanced." 5. Ericsson (ERIC) downgraded to Sell from Neutral at New Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/19
EVER
06/11/19
INITIATION
Target $56
EVER
In Line
General Mills initiated with an In Line at Evercore ISI
Evercore ISI analyst David Palmer started General Mills with an In Line rating and $56 price target.
06/27/19
SBSH
06/27/19
NO CHANGE
Target $60
SBSH
Buy
General Mills earnings selloff a buying opportunity, says Citi
Citi analyst David Driscoll views yesterday's post-earnings pullback in shares of General Mills as a buying opportunity. The analyst keeps a Buy rating on the shares with a $60 price target. The company's retail sales for its North America operations in the quarter were actually flattish, with the delta between reported shipments and takeaway being driven largely by retailer inventory reductions, Driscoll tells investors in a research note. The analyst views General Mills' fiscal 2020 guidance as achievable and keeps the stock as a top pick.

TODAY'S FREE FLY STORIES

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Hot Stocks
Kimberly-Clark CEO says 'we made excellent progress in the second quarter' »

CEO Mike Hsu said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LECO

Lincoln Electric

$85.18

0.39 (0.46%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lincoln Electric reports Q2 adjusted EPS $1.28, consensus $1.27 »

Reports Q2 revenue $777M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Lockheed Martin raises FY19 EPS view to $20.85-$21.15 from $20.05-$20.35 »

Consensus is $20.57.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

INGR

Ingredion

$80.40

-0.705 (-0.87%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Recommendations
Ingredion analyst commentary  »

Ingredion price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 22

    Aug

  • 19

    Sep

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:32
07/23/19
07/23
07:32
07/23/19
07:32
Earnings
Kimberly-Clark raises FY19 adj. EPS view to $6.65-$6.80 from $6.50-$6.70 »

FY19 consensus $6.72. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SEDG

SolarEdge

$63.08

-0.2 (-0.32%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Recommendations
SolarEdge analyst commentary  »

SolarEdge price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

07:31
07/23/19
07/23
07:31
07/23/19
07:31
Earnings
Lockheed Martin reports Q2 EPS $5.00, consensus $4.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CDNS

Cadence Design

$72.68

-0.21 (-0.29%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Recommendations
Cadence Design analyst commentary  »

Cadence Design price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$134.40

-1.31 (-0.97%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Earnings
Kimberly-Clark reports Q2 adjusted EPS $1.67, consensus $1.61 »

Reports Q2 revenue $4.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

T

AT&T

$32.14

-0.63 (-1.92%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 30

    Jul

  • 08

    Aug

WDDMF

WeedMD

$0.00

(0.00%)

07:30
07/23/19
07/23
07:30
07/23/19
07:30
Hot Stocks
WeedMD launches cannabis extraction affiliate CX Industries »

WeedMD announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

, GFI

Gold Fields

$5.51

-0.16 (-2.82%)

07:28
07/23/19
07/23
07:28
07/23/19
07:28
Hot Stocks
Asanko Gold outlines 2H19 exploration program »

Asanko Gold (AKG)…

AKG

Asanko Gold

$0.83

0.0341 (4.29%)

GFI

Gold Fields

$5.51

-0.16 (-2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

, MSFT

Microsoft

$138.41

1.79 (1.31%)

07:27
07/23/19
07/23
07:27
07/23/19
07:27
Initiation
Adaptive Biotechnologies, Microsoft, Roche initiated  »

Adaptive Biotechnologies…

ADPT

Adaptive Biotechnologies

$39.16

0.61 (1.58%)

MSFT

Microsoft

$138.41

1.79 (1.31%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 04

    Nov

NDAQ

Nasdaq

$101.77

0.05 (0.05%)

07:26
07/23/19
07/23
07:26
07/23/19
07:26
Hot Stocks
Nasdaq signs new agreement with Football Index »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

LII

Lennox

$264.15

-14.91 (-5.34%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Recommendations
Lennox analyst commentary at Credit Suisse »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

07:25
07/23/19
07/23
07:25
07/23/19
07:25
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$2.56

-0.04 (-1.54%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Sorrento Therapeutics analyst commentary at H.C. Wainwright »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$147.16

1.98 (1.36%)

07:23
07/23/19
07/23
07:23
07/23/19
07:23
Recommendations
Hershey analyst commentary at Wells Fargo »

Hershey price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

INAP

Internap

$2.76

-0.23 (-7.69%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Hot Stocks
Internap launches Intelligent Monitoring managed cloud and monitoring service »

Internap Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$105.16

1.14 (1.10%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Initiation
Silicon Labs initiated at Benchmark »

Silicon Labs initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 13

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

07:21
07/23/19
07/23
07:21
07/23/19
07:21
Downgrade
Viveve rating change at Mizuho »

Mizuho double downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$54.64

-0.25 (-0.46%)

07:20
07/23/19
07/23
07:20
07/23/19
07:20
Recommendations
Mondelez analyst commentary at Wells Fargo »

Mondelez price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

INTC

Intel

$51.36

1.1 (2.19%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Initiation
Intel initiated at Benchmark »

Intel initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

TORC

ResTORbio

$11.18

1.15 (11.47%)

07:19
07/23/19
07/23
07:19
07/23/19
07:19
Hot Stocks
ResTORbio completes patient enrollment of Phase 3 PROTECTOR 1 trial »

resTORbio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$264.15

-14.91 (-5.34%)

07:18
07/23/19
07/23
07:18
07/23/19
07:18
Recommendations
Lennox analyst commentary at Wells Fargo »

Lennox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.